Nonetheless, our results suggest that the extracellular pattern recognition, the intracellular antiviral molecules, and the eicosanoid signaling (ie, COX-2) could be components that play a potential role in advanced prostate cancer risk. This evidence concerns the gene PTGS2 and prostate carcinoma.